Home > Analytics > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 507789     NSE : JAGSNPHARM    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Jun 14,2024
Price(EOD): ₹ 344.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 908.42 Cr
Value of ₹ 1 Lac invested in JAGSONPAL PHARMACEUTICALS
on Jun 18,2019 (price: ₹ 26.70)

₹ 1 L

₹ 12.89 L

1W : 1.1% 1M : -4.9% 1Y : -6.8%
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
JAGSONPAL PHARMACEUTICALS 1.1% -4.9% -6.8%
SUN PHARMACEUTICAL INDUSTRIES 1.4% -0.7% 53.4%
CIPLA 2.9% 12.5% 59.5%
DR REDDYS LABORATORIES -0.7% 3.4% 29.5%
ZYDUS LIFESCIENCES -0.5% 2.6% 114.2%
DIVIS LABORATORIES 2% 16.7% 31.5%
MANKIND PHARMA 3.6% 7.3% 47.1%
TORRENT PHARMACEUTICALS 1.3% 7% 58.7%
LUPIN -2% -4.3% 96.3%

FUNDAMENTAL ANALYSIS OF JAGSONPAL PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Mar2024, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 JAGSNPHARM is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF JAGSONPAL PHARMACEUTICALS

 
Valuation Score
[As on : Jun 14,2024 ]

Ratio Standalone
P/E
P/B
P/S
40.5
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 22.46 Cr
[Latest Qtr - Mar2024 - Standalone Results ]

4.85
P/B Calculated based on Book Value of Rs 187.40 Cr
[Latest Year - Mar2024 - Standalone Results ]

4.36
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2024 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 10% undervalued companies ! Discover More →

FAIR VALUE OF JAGSONPAL PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
185%
313%
734%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF JAGSONPAL PHARMACEUTICALS



JAGSONPAL PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF JAGSONPAL PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0
0
0.06
0.02
-
-
-
-
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF JAGSONPAL PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF JAGSONPAL PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-7.93%
-21.41%
-14.07%
-10.45%
-21.58%
-50.91%
-38.04%
-36.65%
QtrlyTrend
-8
Latest Qtr: Mar2024
Quarterly Result Analysis →


JAGSONPAL PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 5% 10.1% 63.5%
S&P BSE MIDSMALLCAP 4.6% 9.7% 65.2%
S&P BSE ALLCAP 2.6% 6.8% 41.1%
S&P BSE HEALTHCARE 1.5% 4.9% 53.5%
No NSE index found

You may also like the below Video Courses


FAQ about JAGSONPAL PHARMACEUTICALS


Is JAGSONPAL PHARMACEUTICALS good for long term investment?

As on Jun 14,2024, the Fundamentals of JAGSONPAL PHARMACEUTICALS look Strong and hence it may be good for long term investment! See Financial Performance of JAGSONPAL PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is JAGSONPAL PHARMACEUTICALS UnderValued or OverValued?

As on Jun 14,2024, JAGSONPAL PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of JAGSONPAL PHARMACEUTICALS ?

As on Jun 14,2024, the Intrinsic Value of JAGSONPAL PHARMACEUTICALS is Rs. 83.23 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 120.65
Fair Value [Median EV / Sales Model] : Rs. 83.23
Fair Value [Median Price / Sales Model] : Rs. 41.27
Estimated Median Fair Value of JAGSONPAL PHARMACEUTICALS : Rs. 83.23

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is JAGSONPAL PHARMACEUTICALS trading at a Premium or Discount?

As on Jun 14,2024, JAGSONPAL PHARMACEUTICALS is trading at a Premium of 313% based on the estimates of Median Intrinsic Value!